Subscribe now

Health

2024 will see a new weight-loss drug that trumps Wegovy and Ozempic

Recently approved in the US, the weight-loss drug Zepbound will reach more people in 2024, with research suggesting its effects trump those of the much talked-about Wegovy and Ozempic

By Clare Wilson

27 December 2023

2R2AKY2 Advertising for Wegovy (semaglutide) weight loss injections in the New York subway on Sunday, April 30, 2023. (? Richard B. Levine)

New weight-loss drugs may bypass the need to inject

Richard Levine/Alamy

It may feel like there has been a stream of stories about drugs used for weight loss in 2023, but get ready for double helpings in 2024. A more potent fat-busting injection will probably enter clinics and we will see further trial results for a smorgasbord of treatments in the pipeline.

Semaglutide, possibly the most talked-about medicine of 2023, was developed to treat diabetes and sold as the self-injectable Ozempic. It works by mimicking the action of a gut hormone called…

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox! We'll also keep you up to date with New Scientist events and special offers.

Sign up

To continue reading, subscribe today with our introductory offers

View introductory offers

No commitment, cancel anytime*

Offer ends 2nd of July 2024.

*Cancel anytime within 14 days of payment to receive a refund on unserved issues.

Inclusive of applicable taxes (VAT)

or

Existing subscribers

Sign in to your account